05
Linical is established in June 2005 in Osaka, Japan by a group of entrepreneurs at a major Japanese pharmaceutical company.
Financial Stability, Quality Delivery
Linical’s history spans nearly two decades in advancing clinical research for new and unmet medical needs. Founded in Japan by leaders in drug development from a pharmaceutical company, Linical has grown to cover the world’s top clinical development regions, including North America, Europe, and Asia-Pacific. Linical is publicly traded on the Tokyo Stock Exchange, providing financial stability with a focus on quality delivery for our clients and the patients we help improve therapies for, all over the world.
20
06
Linical’s second office is opened in Tokyo, Japan.
08
Linical USA is established as the first subsidiary of the Group, marking a major step toward becoming a global CRO.
Linical is listed on the Mothers section of the Tokyo Stock Exchange.
13
Linical successfully expands its business by establishing Linical Taiwan and Linical Korea.
Linical’s listing changes to the First Section of the Tokyo Stock Exchange.
14
Linical expands its Asian and European operations.
Linical Korea merges with P-Pro. Korea Co., LTD, a CRO in Korea.
Linical Europe is formed through the acquisition of Nuvisan CDD Holding GmbH, a European CRO.
15
Linical further expands its global footprint, establishing Linical Singapore and Linical UK.
16
Linical continues to grow across Europe, with the formation of Linical Poland.
17
Linical Czech Republic is established, continuing the organization’s expansion in Europe.
18
Linical acquires Accelovance, Inc., a CRO headquartered in US, increasing its presence as a global CRO.
19
Linical further expands its Asian and European operations, with the formation of Linical Hungary and Linical China.
Linical’s History
20
05
Linical is established in June 2005 in Osaka, Japan by a group of entrepreneurs at a major Japanese pharmaceutical company.
06
Linical’s second office is opened in Tokyo, Japan.
08
Linical USA is established as the first subsidiary of the Group, marking a major step toward becoming a global CRO.
Linical is listed on the Mothers section of the Tokyo Stock Exchange.
13
Linical successfully expands its business by establishing Linical Taiwan and Linical Korea.
Linical’s listing changes to the First Section of the Tokyo Stock Exchange.
14
Linical expands its Asian and European operations.
Linical Korea merges with P-Pro. Korea Co., LTD, a CRO in Korea.
Linical Europe is formed through the acquisition of Nuvisan CDD Holding GmbH, a European CRO.
15
Linical further expands its global footprint, establishing Linical Singapore and Linical UK.
16
Linical continues to grow across Europe, with the formation of Linical Poland.
17
Linical Czech Republic is established, continuing the organization’s expansion in Europe.
18
Linical acquires Accelovance, Inc., a CRO headquartered in US, increasing its presence as a global CRO.
19
Linical further expands its Asian and European operations, with the formation of Linical Hungary and Linical China.
20
Successful clinical trials start with Linical.
Don’t let the complex clinical development journey hold you back. With Linical, you can overcome obstacles, save valuable time and money, and reach your goals.
01 Request a proposal
We start by listening to your needs and understanding your goals to ensure we’re the right CRO for you.
02 Get a plan for success
We propose solutions that proactively tackle obstacles, optimize your trial design, and position you for success every step of the way.
03 Execute with confidence
We’ll guide you through each phase of the process, offering personalized support and a full range of services to help you achieve a successful trial. We are not a “one size fits all” CRO.
.webp?width=518&height=780&name=cta-img%20(2).webp)